• About Us
    • Corporate Profile
    • Global Footprint
    • Our Key Milestones
    • BOD
  • manufacturing
    • Infrastructure
    • Dosage Forms & Capacities
  • products & services
    • Products
    • Services
    • Join Hands With Naxpar
  • Investor relations
    • Financials
    • Shareholders Information
    • Compliance
    • Disclosure under Regulation 46 & 62 of SEBI (LODR) Regulations, 2015
    • Investor Contact
  • Catalogues
    • Naxpar Specialities
    • Naxpar Generics
  • Contact Us
    • Contact Us
    • Adverse Event Reporting
Corporate GovernanceReport

2024 – 2025

PDF
Corporate Governance Report for the Quarter Ended December
2024
Download
PDF
Corporate Governance Report for the Quarter Ended June
2024
Download
PDF
Corporate Governance Report for the Quarter Ended September
2024
Download

2023 – 2024

PDF
Corporate Governance Report for the Quarter Ended June
2023
Download
PDF
Corporate Governance Report for the Quarter Ended September 2023
Download
PDF
Corporate Governance Report for the Quarter Ended December 2023
Download
PDF
Corporate Governance Report for the Quarter Ended March 2024
Download

2022 – 2023

PDF
Corporate Governance Report for the Quarter Ended December, 2022
Download
PDF
Corporate Governance Report for the Quarter Ended March 2023
Download

Copyrights Reserved 2008-2025. Naxpar Group